A Prospective Cohort Study of Compound Nanxing Zhitong Ointment
Unknown statusNCT05201365
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to evaluate the safety and the efficacy of compound Nanxing pain relief cream in the treatment of chronic pain in the musculoskeletal system
Study details
- Official title
- A Prospective Cohort Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Musculoskeletal Pain
- Conditions
- Sponsor
- Jiangsu Kanion Pharmaceutical Co., Ltd
- Start date
- 2022-01
- Primary completion
- 2023-01
- Sex
- All
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Attendance at orthopedic, rheumatology and pain clinics for. Exclusion Criteria: * Indication for surgery.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05201365